Cargando…
CAR-T Cells Immunotherapies for the Treatment of Acute Myeloid Leukemia—Recent Advances
SIMPLE SUMMARY: Despite intensive standard treatment, acute myeloid leukemia (AML) continues to be associated with a poor prognosis due to treatment resistance and a high risk of relapse. For this reason, it is necessary to develop new therapeutic strategies, which, when used in combination with sta...
Autores principales: | Zarychta, Julia, Kowalczyk, Adrian, Krawczyk, Milena, Lejman, Monika, Zawitkowska, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252035/ https://www.ncbi.nlm.nih.gov/pubmed/37296906 http://dx.doi.org/10.3390/cancers15112944 |
Ejemplares similares
-
Electrochemical and Optical Sensors for the Detection of Chemical Carcinogens Causing Leukemia
por: Kowalczyk, Adrian, et al.
Publicado: (2023) -
Recent Advances in Treatment Options for Childhood Acute Lymphoblastic Leukemia
por: Malczewska, Marta, et al.
Publicado: (2022) -
Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy
por: Śliwa-Tytko, Patrycja, et al.
Publicado: (2022) -
Molecular-Targeted Therapy of Pediatric Acute Myeloid Leukemia
por: Obszański, Piotr, et al.
Publicado: (2022) -
Genomic Analyses of Pediatric Acute Lymphoblastic Leukemia Ph+ and Ph-Like—Recent Progress in Treatment
por: Kaczmarska, Agnieszka, et al.
Publicado: (2021)